The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
News
Kineret receives positive CHMP opinion for treatment of COVID-19 pneumonia
The European Medicines Agency has recommended approval for use of Kineret in COVID-19 to the European Commission, which will issue a final decision.
NICE recommend venetoclax and azacytidine for patients with aggressive blood cancer
Venetoclax is an oral once-daily treatment, which blocks the action of the B-cell lymphoma-2 protein, the presence of which helps cancer cells survive.
Study finds Omicron multiplies 70 times faster than Delta, UK COVID-19 cases exceed 75,000
A warning has been issued to UK MPs from the head of NHS England that hospitalisations could exceed numbers recorded in January 2021.
Needle free COVID-19 vaccine trialled in UK
The DIOSvax technology produced by the University of Southampton aims to predict how the virus could mutate.
Vaccines still provide ‘significant protection’ against severe COVID-19
Omicron has been the latest variant to test the effectiveness of COVID-19 vaccines.
UK COVID-19 vaccine pledge faces logistical challenges
The public have been assured more sites, mobile units and pop-ups would be set up across the country to fulfill the vaccination pledge ahead of the original deadline of 31 January 2022.
SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation
Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland for patients who have previously failed fluoropyrimidine-based chemotherapy.
European Commission approves Pfizer’s atopic dermatitis treatment
The approval from the European Commission (EC) is based on the results of five clinical studies, involving over 2,800 patients.
Five-drug combination for ultra-high-risk bone marrow cancer identified
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
NHS waiting times reach record high of nearly six million
In October 2021, over 356,000 people in England had been waiting for over six weeks for a key diagnostic test
Health minister welcomes new treatments for COVID-19 patients
The treatments are being offered as an addition to vaccinations to maximise protection against COVID-19
NICE publish final guidance recommending Aspaveli in adults with ultra-rare blood disorder
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK
Cancer clinical trial recruitment drops by 60% during pandemic
In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services
Marketing authorisation acquired for first and only transdermal contraceptive patch in UK
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
